Lycogarubin C

Lycogarubin C

SCHEMBL12658123

COC(=O)c1[nH]c(C(=O)OC)c(-c2c[nH]c3ccccc23)c1-c1c[nH]c2ccccc12

nearest known ligand 0.81

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR4A2 P43354 3/20 0.59
▸ CREBBP Q92793 1/20 0.59
▸ MAPT P10636 4/20 0.55
▸ HTT P42858 2/20 0.55
▸ ALPL P05186 1/20 0.55
▸ MEN1 O00255 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ TUBB4A P04350 1/20 0.50
▸ TUBB P07437 1/20 0.50
▸ TUBA3C P0DPH7 1/20 0.50
▸ TUBA1B P68363 1/20 0.50
▸ TUBA4A P68366 1/20 0.50
▸ TUBB4B P68371 1/20 0.50
▸ TUBB3 Q13509 1/20 0.50
▸ TUBB2A Q13885 1/20 0.50
▸ TUBB8 Q3ZCM7 1/20 0.50
▸ TUBA3E Q6PEY2 1/20 0.50
▸ TUBA1A Q71U36 1/20 0.50
▸ TUBA1C Q9BQE3 1/20 0.50
▸ TUBB6 Q9BUF5 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lycogarubin C SCHEMBL30742812 1.00 NR4A2 (0.59) NR4A2CREBBPMAPTHTTALPL
Lycogarubin B SCHEMBL31061720 0.90 HTT (0.50) NR4A2CREBBPMAPTHTTALPL
SCHEMBL12658122 0.89 MAPT (0.49) NR4A2CREBBPMAPTHTTALPL
Lynamicin E SCHEMBL12658018 0.89 NR4A2 (0.56) NR4A2CREBBPMAPTHTTALPL
SCHEMBL12658224 0.89 PIM1 (0.55) NR4A2CREBBPMAPTHTTALPL
SCHEMBL12658025 0.89 ALPL (0.49) NR4A2CREBBPMAPTHTTALPL
SCHEMBL12658127 0.87 NR4A2 (0.57) NR4A2CREBBPMAPTHTTALPL
SCHEMBL12658217 0.82 MAPT (0.43) NR4A2CREBBPMAPTHTTALPL
Lycogalic Acid A SCHEMBL29465596 0.81 ALDH1A1 (0.54) MAPTMEN1KMT2AALDH1A1NPSR1
Lycogalic Acid A SCHEMBL12955978 0.81 ALDH1A1 (0.54) MAPTMEN1KMT2AALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1711486-B1 BIS-INDOLE PYRROLES USEFUL AS ANTIMICROBIAL AGENTS NEREUS PHARMACEUTICALS INC (US) 2011-05-11 — — EP disclosed
US-7375129-B2 Bis-indole pyrroles useful as antimicrobials agents NEREUS PHARMACEUTICALS, INC. (US) 2008-05-20 — — US disclosed
US-7375129-B2 Bis-indole pyrroles useful as antimicrobials agents NEREUS PHARMACEUTICALS, INC. (US) 2008-05-20 — — US disclosed
US-20070149601-A1 Bis-indole pyrroles useful as antimicrobials agents PRIVATE LIFE BIOMED AG (DE) 2007-06-28 — — US disclosed
US-20070149601-A1 Bis-indole pyrroles useful as antimicrobials agents PRIVATE LIFE BIOMED AG (DE) 2007-06-28 — — US disclosed
US-7166634-B2 Bis-indole pyrroles useful as antimicrobials agents NEREUS PHARMACEUTICALS, INC. (US) 2007-01-23 — — US disclosed
US-7166634-B2 Bis-indole pyrroles useful as antimicrobials agents NEREUS PHARMACEUTICALS, INC. (US) 2007-01-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070149601-A1 Bis-indole pyrroles useful as antimicrobials agents IDO1, IDO2, TPH1 NR4A2 4802/4885CREBBP 1797/4885MAPT 1564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback